Impact of Cytoreductive Nephrectomy on Eligibility for Systemic Treatment and Effects on Survival: Are Surgical Complications or Disease Related Factors Responsible? (Q64449026)

From Wikidata

Jump to navigation Jump to search

scientific article published on July 20, 2011

Language	Label	Description	Also known as
English	Impact of Cytoreductive Nephrectomy on Eligibility for Systemic Treatment and Effects on Survival: Are Surgical Complications or Disease Related Factors Responsible?	scientific article published on July 20, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777963 AND SRC:MED&resulttype=core&format=json

8 February 2020

Impact of cytoreductive nephrectomy on eligibility for systemic treatment and effects on survival: are surgical complications or disease related factors responsible? (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777963 AND SRC:MED&resulttype=core&format=json

8 February 2020

Impact of Cytoreductive Nephrectomy on Eligibility for Systemic Treatment and Effects on Survival: Are Surgical Complications or Disease Related Factors Responsible? (English)

1 reference

10.1016/J.UROLOGY.2011.03.009

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 December 2024

4

object named as

Hyung L. Kim

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21777963

7 December 2024

author name string

Willie Underwood

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777963 AND SRC:MED&resulttype=core&format=json

8 February 2020

Roberto Pili

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777963 AND SRC:MED&resulttype=core&format=json

8 February 2020

Thomas Schwaab

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777963 AND SRC:MED&resulttype=core&format=json

8 February 2020

Rebecca L. O'Malley

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21777963

7 December 2024

Katherine A. Brewer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21777963

7 December 2024

Matthew H. Hayn

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21777963

7 December 2024

language of work or name

0 references

publication date

20 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777963 AND SRC:MED&resulttype=core&format=json

8 February 2020

full work available at URL

https://api.elsevier.com/content/article/PII:S0090429511002718?httpAccept=text/xml

1 reference

10.1016/J.UROLOGY.2011.03.009

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 December 2024

https://api.elsevier.com/content/article/PII:S0090429511002718?httpAccept=text/plain

1 reference

10.1016/J.UROLOGY.2011.03.009

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 December 2024

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777963 AND SRC:MED&resulttype=core&format=json

8 February 2020

78

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777963 AND SRC:MED&resulttype=core&format=json

8 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777963 AND SRC:MED&resulttype=core&format=json

8 February 2020

595-600

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777963 AND SRC:MED&resulttype=core&format=json

8 February 2020

Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis

1 reference

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 January 2021

Prospective clinical trial of preoperative sunitinib in patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 January 2021

Sunitinib for treatment of advanced renal cell cancer: primary tumor response

1 reference

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 January 2021

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

1 reference

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 January 2021

Quality of complication reporting in the surgical literature

1 reference

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 January 2021

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

1 reference

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 January 2021

Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology

1 reference

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 January 2021

A new equation to estimate glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 January 2021

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer

1 reference

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 January 2021

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

1 reference

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 January 2021

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy

1 reference

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 January 2021

Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 January 2021

Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 January 2021

Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy.

1 reference

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 January 2021

Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology--is up-front resection indicated and, if not, is it avoidable?

1 reference

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 January 2021

Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology

1 reference

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 January 2021

Percutaneous Biopsy of Primary Tumor in Metastatic Renal Cell Carcinoma to Predict High Risk Pathological Features: Comparison With Nephrectomy Assessment

1 reference

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 January 2021

Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management

1 reference

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 January 2021

The Value of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy

1 reference

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 January 2021

The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy

1 reference

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 January 2021

Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy

12

1 reference

10.1016/J.UROLOGY.2011.03.009

https://api.crossref.org/works/10.1016/J.UROLOGY.2011.03.009

7 December 2024

Identifiers

10.1016/J.UROLOGY.2011.03.009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777963 AND SRC:MED&resulttype=core&format=json

8 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21777963 AND SRC:MED&resulttype=core&format=json

8 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64449026&oldid=2284593124"